Journal of International Reproductive Health/Family Planning ›› 2025, Vol. 44 ›› Issue (1): 36-40.doi: 10.12280/gjszjk.20240387
• Review • Previous Articles Next Articles
Received:
2024-08-12
Published:
2025-01-15
Online:
2025-01-22
Contact:
LIU Pei-hao, E-mail: YAO Xiang-yi, LIU Pei-hao. Progress in the Application of Dual Trigger in Assisted Reproductive Technology[J]. Journal of International Reproductive Health/Family Planning, 2025, 44(1): 36-40.
Add to citation manager EndNote|Ris|BibTeX
[1] | Palomba S, Costanzi F, Nelson SM, et al. Interventions to prevent or reduce the incidence and severity of ovarian hyperstimulation syndrome: a systematic umbrella review of the best clinical evidence[J]. Reprod Biol Endocrinol, 2023, 21(1):67. doi: 10.1186/ s12958-023-01113-6. |
[2] | Humaidan P, Haahr T. GnRHa trigger-the story of the ugly duckling[J]. F S Rep, 2023, 4(Suppl 2):15-19. doi: 10.1016/j.xfre.2023.02.011. |
[3] | Carosso AR, Canosa S, Gennarelli G, et al. Luteal Support with very Low Daily Dose of Human Chorionic Gonadotropin after Fresh Embryo Transfer as an Alternative to Cycle Segmentation for High Responders Patients Undergoing Gonadotropin-Releasing Hormone Agonist-Triggered IVF[J]. Pharmaceuticals(Basel), 2021, 14(3):228. doi: 10.3390/ph14030228. |
[4] | Huang CY, Shieh ML, Li HY. The benefit of individualized low-dose hCG support for high responders in GnRHa-triggered IVF/ICSI cycles[J]. J Chin Med Assoc, 2016, 79(7):387-393. doi: 10.1016/j.jcma.2016.02.006. |
[5] | 林晓霞, 谭展虹, 蔡冰红, 等. PCOS患者拮抗剂方案双扳机与绒促性素扳机方案的临床应用[J]. 中国处方药, 2021, 19(2):108-109. doi: 10.3969/j.issn.1671-945X.2021.02.056. |
[6] | O′Neill KE, Senapati S, Maina I, et al. GnRH agonist with low-dose hCG (dual trigger) is associated with higher risk of severe ovarian hyperstimulation syndrome compared to GnRH agonist alone[J]. J Assist Reprod Genet, 2016, 33(9):1175-1184. doi: 10.1007/s10815-016-0755-8. |
[7] |
Griffin D, Benadiva C, Kummer N, et al. Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose human chorionic gonadotropin to optimize live birth rates in high responders[J]. Fertil Steril, 2012, 97(6):1316-1320. doi: 10.1016/j.fertnstert.2012.03.015.
pmid: 22480822 |
[8] | 李蓉, 陈福锐, 陈诗琪, 等. 三种扳机方式在多囊卵巢综合征患者拮抗剂方案促排卵中的临床应用[J]. 生殖医学杂志, 2023, 32(11):1623-1629. doi: 10.3969/j.issn.1004-3845.2023.11.002. |
[9] | Xu K, Wang J, Yang S, et al. Comparison of HCG Trigger versus Dual Trigger in Improving Pregnancy Outcomes in Patients with Different Ovarian Responses: A Retrospective Study[J]. Int J Endocrinol, 2024,2024:2507026. doi: 10.1155/2024/2507026. |
[10] | 沈秀珍, 沈新光, 王芳敏. 促性腺激素释放激素激动剂联合小剂量人绒毛膜促性腺激素双扳机在卵巢高反应患者拮抗剂促排卵周期中的应用效果[J]. 中国性科学, 2021, 30(6):84-87. doi: 10.3969/j.issn.1672-1993.2021.06.026. |
[11] | He Y, Tang Y, Chen S, et al. Effect of GnRH agonist alone or combined with different low-dose hCG on cumulative live birth rate for high responders in GnRH antagonist cycles: a retrospective study[J]. BMC Pregnancy Childbirth, 2022, 22(1):172. doi: 10.1186/s12884-022-04499-0. |
[12] |
Wang Q, Wan Q, Li T, et al. Effect of GnRH agonist trigger with or without low-dose hCG on reproductive outcomes for PCOS women with freeze-all strategy: a propensity score matching study[J]. Arch Gynecol Obstet, 2024, 309(2):679-688. doi: 10.1007/s00404-023-07285-1.
pmid: 38032411 |
[13] | He FF, Hu W, Yong L, et al. Triggering of ovulation for GnRH-antagonist cycles in normal and low ovarian responders undergoing IVF/ICSI: A systematic review and meta-analysis of randomized trials[J]. Eur J Obstet Gynecol Reprod Biol, 2023, 289:65-73. doi: 10.1016/j.ejogrb.2023.08.014. |
[14] | Zhang Y, Guo X, Guo L, et al. Outcomes comparison of IVF/ICSI among different trigger methods for final oocyte maturation: A systematic review and meta-analysis[J]. FASEB J, 2021, 35(7):e21696. doi: 10.1096/fj.202100406R. |
[15] | Gao F, Wang Y, Fu M, et al. Effect of a "Dual Trigger" Using a GnRH Agonist and hCG on the Cumulative Live-Birth Rate for Normal Responders in GnRH-Antagonist Cycles[J]. Front Med(Lausanne), 2021,8:683210. doi: 10.3389/fmed.2021.683210. |
[16] |
Guo D, Pang C, Wang K. Comparison of pregnancy outcomes in women with normal ovarian response to the gonadotropin-releasing hormone agonist protocol using different trigger methods: a single-center retrospective cohort study based on propensity score matching[J]. Arch Gynecol Obstet, 2024, 309(5):2153-2165. doi: 10.1007/s00404-024-07404-6.
pmid: 38494512 |
[17] |
Li Q, Li X, Li T, et al. Comparison of an HCG-only trigger versus dual trigger for final oocyte maturation in a progestin-primed ovarian stimulation protocol[J]. Reprod Biomed Online, 2022, 45(6):1176-1181. doi: 10.1016/j.rbmo.2022.08.101.
pmid: 36207251 |
[18] | 冼业星, 黄岩, 郭新宇. 空卵泡综合征研究进展[J]. 中国优生与遗传杂志, 2022, 30(10):1893-1898. doi: 10.13404/j.cnki.cjbhh.2022.10.015. |
[19] | Turathum B, Gao EM, Chian RC. The Function of Cumulus Cells in Oocyte Growth and Maturation and in Subsequent Ovulation and Fertilization[J]. Cells, 2021, 10(9):2292. doi: 10.3390/cells10092292. |
[20] | Hsia LH, Lee TH, Lin YH, et al. Dual trigger improves the pregnancy rate in fresh in vitro fertilization (IVF) cycles compared with the human chorionic gonadotropin (hCG) trigger: a systematic review and meta-analysis of randomized trials[J]. J Assist Reprod Genet, 2023, 40(9):2063-2077. doi: 10.1007/s10815-023-02888-8. |
[21] | Tulek F, Kahraman A, Demirel LC. Dual trigger with gonadotropin releasing hormone agonist and human chorionic gonadotropin improves live birth rates in POSEIDON group 3 and 4 expected poor responders[J]. Gynecol Endocrinol, 2022, 38(9):731-735. doi: 10.1080/09513590.2022.2101635. |
[22] | Sloth A, Kjølhede M, Sarmon KG, et al. Effect of dual trigger on reproductive outcome in low responders: a systematic PRISMA review and meta-analysis[J]. Gynecol Endocrinol, 2022, 38(3):213-221. doi: 10.1080/09513590.2021.2000962. |
[23] | Kang MK, Kim MK, Kim TH, et al. Association between different dual trigger dosages and in vitro fertilization results in patients with patient-oriented strategies encompassing individualized oocyte number group Ⅳ[J]. Obstet Gynecol Sci, 2022, 65(2):215-222. doi: 10.5468/ogs.21317. |
[24] | Gan R, Huang X, Zhao J, et al. Time interval between hCG administration and oocyte retrieval and ART outcomes: an updated systematic review and meta-analysis[J]. Reprod Biol Endocrinol, 2023, 21(1):61. doi: 10.1186/s12958-023-01110-9. |
[25] | Ranit H, Shmuel H, Ahlad A, et al. Is there a preferred time interval between gonadotropin-releasing hormone (GnRH) agonist trigger and oocyte retrieval in GnRH antagonist cycles? A retrospective cohort of planned fertility preservation cycles[J]. J Assist Reprod Genet, 2024, 41(6):1531-1538. doi: 10.1007/s10815-024-03083-z. |
[26] | Sharma B, Koysombat K, Comninos AN, et al. Use of kisspeptin to trigger oocyte maturation during in vitro fertilisation (IVF) treatment[J]. Front Endocrinol(Lausanne), 2022,13:972137. doi: 10.3389/fendo.2022.972137. |
[27] |
Abbara A, Clarke SA, Dhillo WS. Clinical Potential of Kisspeptin in Reproductive Health[J]. Trends Mol Med, 2021, 27(8):807-823. doi: 10.1016/j.molmed.2021.05.008.
pmid: 34210598 |
[28] |
Abbara A, Jayasena CN, Christopoulos G, et al. Efficacy of Kisspeptin-54 to Trigger Oocyte Maturation in Women at High Risk of Ovarian Hyperstimulation Syndrome (OHSS) During In Vitro Fertilization (IVF) Therapy[J]. J Clin Endocrinol Metab, 2015, 100(9):3322-3331. doi: 10.1210/jc.2015-2332.
pmid: 26192876 |
[29] | Abbara A, Islam R, Clarke SA, et al. Clinical parameters of ovarian hyperstimulation syndrome following different hormonal triggers of oocyte maturation in IVF treatment[J]. Clin Endocrinol(Oxf), 2018, 88(6):920-927. doi: 10.1111/cen.13569. |
[1] | WANG Jia-yi, JI Hui, LI Xin, LING Xiu-feng. Effect of Serum β-hCG Level on the Next Day of Dual Trigger in Antagonist Regimen on the Outcome of Fresh Embryo Transfer [J]. Journal of International Reproductive Health/Family Planning, 2024, 43(6): 447-452. |
[2] | ZHU Hai-ying, QI Dan-dan, SUN Ping-ping, SUN Na, LUAN Su-xian. A Case Report of Ovarian Hyperstimulation Syndrome Combined with Ovarian Torsion after Assisted Reproductive Technology Assisted Pregnancy [J]. Journal of International Reproductive Health/Family Planning, 2024, 43(5): 401-405. |
[3] | YE Lin, HOU Zhi-jin, MENG Yu-shi. Research Progress of Sirolimus in the Field of Reproduction [J]. Journal of International Reproductive Health/Family Planning, 2024, 43(2): 132-137. |
[4] | QIU Meng-zhen, SHANG Jin, TU Xiao-jun, LI Jie. Ovarian Hyperstimulation Syndrome Complicated with Superior Mesenteric Venous Thrombosis and Portal Vein Thrombosis: A Case Report [J]. Journal of International Reproductive Health/Family Planning, 2023, 42(3): 213-217. |
[5] | ZHOU Duo, LI Heng-jing, LU Guang-mei, HUANG Qiu-fang, ZHANG Yi. A Case of Spontaneous Ovarian Hyperstimulation Syndrome in Pregnancy [J]. Journal of International Reproductive Health/Family Planning, 2022, 41(4): 298-301. |
[6] | SONG Yun-jie, ZHANG Yuan, XIA Xin-ru, XIA Meng, WU Wei, HUANG Jie, DIAO Fei-yang, MAO Yun-dong, LIU Jia-yin, ZHANG Ru-yang, MA Xiang. Application of Increasing hCG Trigger Dose in Patients with Poor Ovarian Response [J]. Journal of International Reproductive Health/Family Planning, 2021, 40(6): 441-445. |
[7] | LI Wen-shu, LIU Xue-mei. Application of Follicular Phase Long-Acting GnRH Agonist Long Protocol in IVF [J]. Journal of International Reproductive Health/Family Planning, 2021, 40(5): 407-410. |
[8] | QIN Yi-ming, KONG Xin-liang, ZHANG Jian-wei. Research Progress of Trigger Scheme in Ovarian Hyperstimulation Cycles in Infertile Women with Polycystic Ovary Syndrome [J]. Journal of International Reproductive Health/Family Planning, 2021, 40(3): 226-230. |
[9] | WEI Chao-feng, LIAN Fang. Effects of Different Triggering Patterns on Oocyte Maturation and Pregnancy Outcome during Antagonist Regimen [J]. Journal of International Reproductive Health/Family Planning, 2020, 39(5): 361-364. |
[10] | ZHOU Yan-qiong,GUI Wen-wu. Research Progress of Human Chorionic Gonadotropin Adminstration in Embryo Transfer [J]. Journal of International Reproductive Health/Family Planning, 2020, 39(3): 237-241. |
[11] | WANG Chun-qiao,ZHENG Jing. Research Progress on the Relationship between Early Threatened Abortion and Carbohydrate Antigen 125 [J]. Journal of International Reproductive Health/Family Planning, 2020, 39(3): 247-250. |
[12] | WANG Bao-juan,SONG Jia-yi,GONG Zheng,XIA Tian,MA Rui-hong. Assisted Pregnancy Strategy for Patients with Clomiphene-Resistant Polycystic Ovary Syndrome [J]. Journal of International Reproductive Health/Family Planning, 2020, 39(2): 163-166. |
[13] | CHAI Yi-hong,YANG Pan-pan,ZHANG Xue-hong. Research Progress on Trigger Schemes in Assisted Reproductive Technology [J]. Journal of International Reproductive Health/Family Planning, 2020, 39(1): 59-62. |
[14] | XU Yuan-fang,HUANG Yuan-hua. Evaluation of Ovarian Reserve Function by AMH in Patients with PCOS and Its Diagnostic Value [J]. Journal of International Reproductive Health/Family Planning, 2019, 38(3): 230-235. |
[15] | JIANG Lei,HAO Gui-min,XU Xin,WAN Fang-fang. Ovarian Hyperstimulation Syndrome after In Vitro Fertilization-Embryo Transfer, with Increased Level of CA125: A Case Report [J]. Journal of International Reproductive Health/Family Planning, 2019, 38(2): 124-126. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||